Faced with lower US profits, pharmaceutical companies could demand higher prices elsewhere in the world, or even withdraw products entirelyGet our breaking news email, free app or daily news podcastDonald Trump’s pressure on medicine companies could drive up the cost of Australia’s Pharmaceutical Benefits Scheme (PBS) or see companies withdraw some medicines from Australian shelves , experts have warned.The US president on Monday threatened to force medicine companies to lower their prices in the US, giving them 30 days to cut costs or face more severe action in an executive order.Sign up for Guardian Australia’s breaking news email Continue reading...
Continua a leggere su "The Guardian"